Intracavitary contrast-enhanced ultrasonography in children: review with procedural recommendations and clinical applications from the European Society of Paediatric Radiology abdominal imaging task force.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0365332 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1998 (Electronic) Linking ISSN: 03010449 NLM ISO Abbreviation: Pediatr Radiol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Berlin, New York, Springer-Verlag.
    • Subject Terms:
      Contrast Media*; Biliary Tract Diseases/*diagnostic imaging ; Female Urogenital Diseases/*diagnostic imaging ; Gastrointestinal Diseases/*diagnostic imaging ; Image Enhancement/*methods ; Male Urogenital Diseases/*diagnostic imaging ; Ultrasonography/*methods; Abdominal Cavity/diagnostic imaging ; Adolescent ; Child ; Child, Preschool ; Europe ; Female ; Humans ; Infant ; Male ; Pediatrics ; Societies, Medical
    • Abstract:
      Contrast-enhanced ultrasonography (US) has become an important supplementary tool in many clinical applications in children. Contrast-enhanced voiding urosonography and intravenous US contrast agents have proved useful in routine clinical practice. Other applications of intracavitary contrast-enhanced US, particularly in children, have not been widely investigated but could serve as a practical and radiation-free problem-solver in several clinical settings. Intracavitary contrast-enhanced US is a real-time imaging modality similar to fluoroscopy with iodinated contrast agent. The US contrast agent solution is administered into physiological or non-physiological body cavities. There is no definitive list of established indications for intracavitary US contrast agent application. However, intracavitary contrast-enhanced US can be used for many clinical applications. It offers excellent real-time spatial resolution and allows for a more accurate delineation of the cavity anatomy, including the internal architecture of complex collections and possible communications within the cavity or with the surrounding structures through fistulous tracts. It can provide valuable information related to the insertion of catheters and tubes, and identify related complications such as confirming the position and patency of a catheter and identifying causes for drainage dysfunction or leakage. Patency of the ureter and biliary ducts can be evaluated, too. US contrast agent solution can be administered orally or a via nasogastric tube, or as an enema to evaluate the gastrointestinal tract. In this review we present potential clinical applications and procedural and dose recommendations regarding intracavitary contrast-enhanced ultrasonography.
    • References:
      Z Gastroenterol. 2015 May;53(5):385-90. (PMID: 25965985)
      Radiology. 2018 Mar;286(3):1033-1039. (PMID: 28980885)
      Pediatr Radiol. 2015 Dec;45(13):2023-8. (PMID: 26626757)
      Pediatr Radiol. 2014 Nov;44(11):1478-84. (PMID: 25331025)
      Pediatr Radiol. 2016 Oct;46(11):1614-7. (PMID: 27350376)
      Radiol Case Rep. 2018 Apr 06;13(3):652-654. (PMID: 30023034)
      BMC Med Imaging. 2017 Jul 6;17(1):39. (PMID: 28683719)
      Pediatr Radiol. 2013 Sep;43(9):1063-73. (PMID: 23843130)
      Eur J Radiol. 2012 Dec;81(12):3846-50. (PMID: 22835875)
      J Ultrasound Med. 2017 Sep;36(9):1943-1954. (PMID: 28626910)
      Pediatr Radiol. 2019 Aug;49(9):1240-1247. (PMID: 31123767)
      Pediatr Radiol. 2018 Sep;48(10):1528-1536. (PMID: 29796794)
      J Pediatr. 2013 Sep;163(3):778-84.e1. (PMID: 23623514)
      Eur Radiol. 2012 Feb;22(2):371-8. (PMID: 21947481)
      J Gastrointestin Liver Dis. 2010 Dec;19(4):439-44. (PMID: 21188338)
      Ultraschall Med. 2018 Apr;39(2):154-180. (PMID: 29510440)
      Radiographics. 2017 Mar-Apr;37(2):652-664. (PMID: 27860550)
      J Pediatr Surg. 2016 Jan;51(1):179-82. (PMID: 26592955)
      Pediatr Radiol. 2014 Jun;44(6):719-28. (PMID: 24442338)
      Eur J Radiol. 2015 Oct;84(10):2024-31. (PMID: 26159485)
      Insights Imaging. 2018 Jun;9(3):303-311. (PMID: 29594851)
      J Urol. 2017 Dec;198(6):1367-1373. (PMID: 28743528)
      Z Gastroenterol. 2014 Oct;52(10):1178-84. (PMID: 25313631)
      J Clin Ultrasound. 2019 Jan;47(1):36-41. (PMID: 30393874)
      Radiology. 2017 Apr;283(1):273-279. (PMID: 28234551)
      Ultraschall Med. 2012 Feb;33(1):76-84. (PMID: 22183864)
      Endoscopy. 2009 Aug;41(8):725-6. (PMID: 19670143)
      Radiol Med. 2008 Jun;113(4):591-8. (PMID: 18478190)
      J Ultrasound Med. 2019 Oct;38(10):2777-2783. (PMID: 30693972)
      Pediatr Radiol. 2017 Sep;47(10):1369-1380. (PMID: 28852767)
      Br J Clin Pharmacol. 2000 Feb;49(2):93-7. (PMID: 10671901)
      J Ultrason. 2013 Dec;13(55):394-407. (PMID: 26674600)
      Ultraschall Med. 2017 Jan;38(1):33-43. (PMID: 27414980)
      Radiology. 2017 Oct;285(1):293-301. (PMID: 28467143)
      J Gastrointestin Liver Dis. 2013 Sep;22(3):349-53. (PMID: 24078996)
      Pediatr Surg Int. 2017 Sep;33(9):1019-1022. (PMID: 28744798)
      J Crohns Colitis. 2019 Apr 26;13(5):593-599. (PMID: 30544185)
      Ultrasound Med Biol. 2018 Feb;44(2):502-507. (PMID: 29229267)
      Clin Radiol. 2019 Feb;74(2):167.e9-167.e16. (PMID: 30415765)
    • Contributed Indexing:
      Keywords: Children; Contrast agents; Contrast-enhanced; Intracavitary; Ultrasound
    • Accession Number:
      0 (Contrast Media)
    • Publication Date:
      Date Created: 20200215 Date Completed: 20210129 Latest Revision: 20210129
    • Publication Date:
      20231215
    • Accession Number:
      10.1007/s00247-019-04611-1
    • Accession Number:
      32055916